Patients & Caregivers

An elderly couple embrace

Exploring new ways to improve and extend people's lives

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues. Only by working together can we improve outcomes for patients and change the practice of medicine.

  • 40+

    Patient Organizations representing

  • 200M

    Patients contributed to its development

  • 108 000

    Novartis associates own it as an aspiration

The four pillars of our Commitment

  • Icon of a handshake

    Respecting and understanding the patient community perspective

  • Icon of a globe

    Expanding access to our medicines

  • Icon of a stethoscope

    Conducting responsible clinical trials

  • Icon of a magnifying glass

    Recognizing the importance of transparency and reporting

Our Focus

Our Commitment to Patients and Caregivers

We recognize the importance of patients and caregivers understanding what they can expect from Novartis.

Learn More

The Commitment to Patients and Caregivers – Reporting 2019 progress

  • 70% Early research programs

    in general medicines obtained patient insights before first in human trials (healthy volunteers). Piloted patient panels for five Proof of Concept indications

  • 10 503 Patients reached through managed access programs

    96.8% requests approved for 34 compounds in 74 countries - providing pre-approval access to Novartis medicines, 81% increase vs. 2018

  • 18 Clinical development programs

    comprising 34 clinical trials, had a patient engagement component to obtain the patient perspective on the design and / or conduct of clinical trials

  • 55 Clinical trials

    included Patient Reported Outcomes (PRO) conducted in 68 countries

  • 50 Simplified summaries

    from Phase 1-4 clinical trials sent to investigators to share with 8,016 trial participants and posted on novartisclinicaltrials.com

  • 16M Patients

    reached through Access programs

Collaborations with Patient Organizations

Patient Organizations and Novartis

We collaborate with patient organizations and healthcare organizations globally in the disease areas for which we provide or are developing medicines. This collaboration is based on values of mutual respect, trust and transparency.

Learn More

Novartis ranks #4 in PatientView’s 2018 reputation survey of patient groups worldwide

PatientView’s 2018 “Corporate Reputation of the Pharmaceutical Industry – from the Patient Perspective” ranked Novartis #4 overall, considered by the patient groups surveyed as number one partner and first in corporate brand awareness.

Learn More

Novartis Investigational Medicines
  • Researchers in lab

    About clinical trials

    Clinical trials are scientific studies conducted to find better ways to prevent, screen for, diagnose or treat disease.

  • A doctor speaks with a patient

    Participating in Novartis clinical trials

    Novartis is currently conducting clinical trials around the world for a number of diseases.

  • Two medication bottles

    Managed Access programs

    Novartis Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases. Your physician may request access.

Patient Perspectives

We commit to actively seeking out and listening to insights from the patient community. Visit our YouTube channel to watch our Patient & Caregiver stories and learn more about our resources.

Watch the Videos

For questions about Novartis, medical inquiries about our products and or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio.